Fiche société
Trigemina, Inc
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications2liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| TI-001This study evaluates the use of oxytocin, given as a nasal spray, for treatment of high frequency episodic migraine and chronic migraine. | Migraine | Phase 2 | À vérifier | Australia, Chile, New Zealand | À vérifier |
| TI-001This study evaluates the use of oxytocin, given as a nasal spray, for treatment of high frequency episodic migraine and chronic migraine. | Migraine | Phase 2 | À vérifier | Australia, Chile, New Zealand | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| TI-001 | Migraine | Phase 2 | NCT01839149 | TI-001 (Intranasal Oxytocin) for Treatment of High Frequency Episodic Migraine and Chronic Migraine | COMPLETED |
Publications
2| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| TI-001 | TiO2 nanotubes: interdependence of substrate grain orientation and growth rate. | ACS applied materials & interfaces | ||
| TI-001 | Active machine learning model for the dynamic simulation and growth mechanisms of carbon on metal surface. | Nature communications |